Acasti Pharma enters new employment agreement with CEO Prashant Kohli

Grace Therapeutics, Inc.

Annual base salary of $500,000 and eligible for discretionary bonus up to 50% of base.
Severance of 12 months' base salary if terminated without cause (including after change of control).
Subject to board approval, may receive stock options under the company's equity incentive plan.
12-month non-compete and non-solicitation clauses; standard benefits and vacation included.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.